Refine the list (min. 2 characters)
Keynote Presentation (In-Person)
To be updated shortly...
Keynote Presentation (In-Person)
Pancreatic cancer (PC) is difficult to treat and has the lowest five-year survival rate across the world. PC is characterized by desmoplasia composed of abundant cancer-associated fibroblasts (CAFs) and excessive extracellular matrix (ECM), which creates a pathological barrier th [....] » Read More
Keynote Presentation (In-Person)
A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based medicine and thus genomics biomarkers promises to provide molecular tests that will pe [....] » Read More
Keynote Presentation (In-Person)
Title: Anti-Cancer Nanomedicine in Humans: 30,000 Successful Cases and Counting
This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 30,000 patients to da [....] » Read More
Keynote Presentation (Virtual)
Title: Targeted gene and drug delivery nanosystems to hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the major causes of cancer mortality worldwide, highlighting the urgent need for the development of new therapeutic approaches, such as those involving the combination of gene therapy and chemotherapy, that potentially present higher thera [....] » Read More
Keynote Presentation (Virtual)
Title: Information Leakage: Types, Remedies, and Open problems
Information Leakage threatens and questions the use of machine learning model in real-life clinical applications. In effect, information leakage is similar to vulgar overfitting, yet rather more subtle and even when detected much harder to remove. Some recent research i [....] » Read More
Oral Presentation (In-Person)
A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). The concept of PPM is becoming increasingly relevant for cancer treatment, moving from the ‘one-size-fits-all’ [....] » Read More
Oral Presentation (In-Person)
Title: Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer
Ferroptosis is an oxidative, non-apoptotic form of cell death that is frequently inactivated in cancer, yet its regulation in oncogene-specific tumors remains poorly understood. Here, we identify lactate dehydrogenase B (LDHB)—but not the closely related LDHA—as a non [....] » Read More
Copyright 2024 Mathews International LLC All Rights Reserved